Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
3.45
-0.09
(-2.54%)
USD |
NASDAQ |
Sep 09, 14:00
Shuttle Pharmaceuticals Holdings Enterprise Value : 1.089M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 1.089M |
| September 04, 2026 | 1.067M |
| September 03, 2026 | 1.056M |
| September 02, 2026 | 1.061M |
| September 01, 2026 | 1.128M |
| August 31, 2026 | 0.9892M |
| August 28, 2026 | 1.089M |
| August 27, 2026 | 1.278M |
| August 26, 2026 | 1.117M |
| August 25, 2026 | 1.034M |
| August 24, 2026 | 1.078M |
| August 21, 2026 | 1.211M |
| August 20, 2026 | 1.184M |
| August 19, 2026 | 1.211M |
| August 18, 2026 | 1.300M |
| August 17, 2026 | 1.40M |
| August 14, 2026 | 1.383M |
| August 13, 2026 | 1.666M |
| August 12, 2026 | 1.472M |
| August 11, 2026 | 1.517M |
| August 10, 2026 | 1.383M |
| August 07, 2026 | 1.544M |
| August 06, 2026 | 1.555M |
| August 05, 2026 | 1.678M |
| August 04, 2026 | 1.150M |
| Date | Value |
|---|---|
| August 03, 2026 | 0.9948M |
| July 31, 2026 | 1.234M |
| July 30, 2026 | 0.8394M |
| July 29, 2026 | 0.6673M |
| July 28, 2026 | 0.6728M |
| July 27, 2026 | 0.745M |
| July 24, 2026 | 0.7283M |
| July 23, 2026 | 0.7838M |
| July 22, 2026 | 0.8227M |
| July 21, 2026 | 0.9837M |
| July 20, 2026 | 0.8061M |
| July 17, 2026 | 0.8782M |
| July 16, 2026 | 1.095M |
| July 15, 2026 | 1.150M |
| July 14, 2026 | 1.433M |
| July 13, 2026 | 0.7672M |
| July 10, 2026 | 0.745M |
| July 09, 2026 | 0.9448M |
| July 08, 2026 | 1.106M |
| July 07, 2026 | 0.9337M |
| July 06, 2026 | 1.067M |
| July 02, 2026 | 1.111M |
| July 01, 2026 | 1.011M |
| June 30, 2026 | 0.9282M |
| June 29, 2026 | 0.9282M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.865B |
| Alnylam Pharmaceuticals, Inc. | 34.46B |
| Anika Therapeutics, Inc. | 268.42M |
| Savara, Inc. | 993.23M |
| Vericel Corp. | 1.932B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.152M |
| Total Expenses (Quarterly) | 2.152M |
| EPS Diluted (Quarterly) | -4.278 |
| Earnings Yield | -1.76K% |
| Normalized Earnings Yield | -1814.48 |